Peru · Findings · Debarred / sanctioned abroad × US SEC issuer
BMY · SUB~ · PE · CONSORCIO BRISTOL MYERS SQUIBB PERU S.A. - PERUFARMA S.A
Why it is here
Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'BRISTOL MYERS SQUIBB PHARMA ~0.80' «CONSORCIO BRISTOL MYERS SQUIBB PERU S.A. - PERUFARMA S.A» ↔ SEC BMY (CIK 14272, BRISTOL MYERS SQUIBB CO): 1 non-competitive contracts at the buyer «SEGURO SOCIAL DE SALUD», 389,786 PEN (≈ $105,242); one bid; OCID ocds-dgv273-seacev3-830990; ⚑ REPEAT: already sanctioned SEC by FCPA (2015-10-05 Bristol-Myers Squibb).
Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.
Details
- Company / subject
- BMY · SUB~ · PE · CONSORCIO BRISTOL MYERS SQUIBB PERU S.A. - PERUFARMA S.A
- Indicator
- Debarred / sanctioned abroad × US SEC issuer
- Amount
- 105,242
- Records behind the indicator
- 1
- Found
- 4 October 2026
- Code
- W-02164
- Reference
- ocds-dgv273-seacev3-830990
- Reference
- 2015-10-05
Other records of this company10
- 014 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
- 024 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
- 034 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
- 044 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
- 054 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
- 064 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
- 074 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
- 084 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
- 094 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
- 104 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer